So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

U.S.-based biotech builder Mountainfield Venture Partners and China’s Keymed Biosciences have launched a new company armed with $180 million in series A funds and a clinical-stage CD38-targeting ...

On Wednesday the U.S. Department of Commerce announced it would implement new export controls on certain biotechnology equipment, citing national security concerns relating to artificial ...

Sana Biotechnology, Inc. stock will be surging today after the company showed it can safely administer its allogeneic cell therapy for diabetes to a patient with no immunosuppression. Engineered ...

Prospective health secretary Robert F. Kennedy Jr. invested in biotechnology and had multiple sources of income in 2022 and 2023, financial disclosures show. The documents, which STAT obtained ...

WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security ...

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells ...

CEO Surbhi Sarna's small team at Collate so far includes founding chief architect Jigish Patel and cofounder and CTO Nate Smith. Surbhi Sarna sold her last startup, nVision Medical, for $275 ...

In addition, only 5% of those polled said they would take action by altering their purchasing habits as a result of concerns associated with using biotech products. According to the Food and ...

This week at the 43rd J.P. Morgan Healthcare Conference, Pops will be touting Alkermes’ rare set of attributes as a self-funded neuroscience biotech ... “The theme for this year [at J.P ...